The NF-κB/Rel transcription factors play an important role in the expression of genes involved in B cell development, differentiation and function. Nuclear NF-κB is induced in B cells by engagement of either the BCR or CD40 or by stimulation with lipopolysaccharide (LPS). Despite the importance of NF-κB to B cell function, little is known about the signaling pathways leading to NF-κB activation. In this report we address the role of phosphoinositide 3Ј-kinase (PI 3-kinase) in BCRand LPS-induced NF-κB activation using populations of primary murine resting B cells. Using the specific pharmacological inhibitors of PI 3-kinase, Wortmannin and LY294002, we demonstrate that PI 3-kinase activity is vital for BCR-induced NF-κB DNA-binding activity. Furthermore, we show that this is achieved via protein kinase C-dependent degradation of IκBα. Similar analyses reveal that PI 3-kinase is also critical in triggering NF-κB DNA-binding activity and IκBα degradation following LPS stimulation. Interestingly, a PKC inhibitor which blocked the BCR-induced IκBα degradation had no effect on the degradation of IκBα after LPS stimulation. Taken together, our results indicate the involvement of PI 3-kinase in at least two distinct signaling pathways leading to activation of NF-κB in B cells.
Introduction
Engagement of the BCR on mature B cells initiates signaling second messengers inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerol (5). In turn, these second messengers stimulate pathways resulting in multiple cellular responses including activation, proliferation and differentiation (1) . Much work has the activity of protein kinase C (PKC) and increase intracellular calcium levels, resulting in activation of downstream transcriprecently gone into defining the signaling events which follow BCR engagement and that ultimately control the fate of mature tion factors (6,7). Activation of PI 3-kinase in response to BCR engagement B cells through activation of various transcription factors. BCR engagement initially results in activation of non-receptor is not well characterized, but both Lyn and Syk have been shown to be involved (8-10). Only the class Ia PI 3-kinases protein tyrosine kinases which include Fyn, Lyn, Syk and Btk (2) . One of the critical downstream events following activation have so far been shown to be activated as part of this process (8,9). The class Ia PI 3-kinases are heterodimeric enzymes of these protein tyrosine kinases is the recruitment of the lipid metabolizing enzymes phospholipase C (PLC)-γ2 and composed of an 85-kDa regulatory subunit (p85) and a 110-kDa catalytic subunit (p110) (11). Once activated, PI 3-kinase phosphoinositide 3Ј-kinase (PI 3-kinase) to the plasma membrane. Activated Btk, together with Syk, phosphorylate and phosphorylates PI(4,5)P 2 on the D3 position of the inositol ring to generate phosphatidylinositol 3,4,5-trisphosphate activate PLC-γ2 (3, 4) , resulting in hydrolysis of phosphatidylinositol 4,5-bisphosphate [PI(4,5)P 2 ], and production of the [PI(3,4,5)P 3 ] (11). This process is critical in normal B cell function, as revealed by studies which demonstrate impaired Although it is clear that BCR stimulation leads to the activation of NF-κB, and despite the importance of NF-κB to proliferation and differentiation of normal human B lymphocytes and of a human B lymphoma cell line following BCR B cell proliferation and differentiation, the mechanism leading to NF-κB activation in B cells is poorly understood. Recent cross-linking in the presence of PI 3-kinase inhibitors (12,13). Further, mice lacking the regulatory p85 subunit of PI 3-studies in other cells suggest the involvement of PI 3-kinase and its downstream kinase Akt in a pathway leading to kinase exhibit profound defects in B cell function, including decreased proliferative responses and impaired survival activation of NF-κB (41) (42) (43) . As PI 3-kinase and NF-κB are both essential for normal B cell function, and in light of (14,15).
Despite the crucial role PI 3-kinase plays in B cells, the these studies, we investigated the significance of PI 3-kinase activation in the NF-κB signaling pathway in primary murine downstream signaling events following PI 3-kinase activation have only recently begun to be addressed. In B cells, the B cells. Using the specific pharmacological inhibitors of PI 3-kinase, Wortmannin and the structurally distinct LY294002 pleckstrin homology (PH) domain-containing kinases Btk and Akt (also termed protein kinase B) are activated in a PI 3-compound, we provide evidence that the lipid products of PI 3-kinase are an important part of the signaling pathway kinase-dependent manner (16-18). Btk, which phosphorylates and activates PLC-γ2, is recruited to the plasma membrane leading to activation of NF-κB by the BCR and LPS. via the binding of its PH domain to PI(3,4,5)P 3 (4, (19) (20) (21) (24) .
excised and cells were dispersed by being pressed through Akt plays an important role in cell survival in various cell types stainless steel gauze. Depletion of erythrocytes was achieved and recently has been demonstrated to be involved in B cell by incubation in ACK lysis buffer (BioWhittaker, Walkersville, survival (25) . In addition, recruitment of the exchange factors MD), followed by washing in HBSS containing 20 mM HEPES. Sos and Vav, which activate Rac1, is facilitated by their B cells were isolated via magnetic cell sorting by negative association with membrane PI(3,4,5)P 3 (26, 27) , pointing selection using anti-CD43 magnetic beads and MACS separatowards a further role for PI 3-kinase in mediating downstream tion columns (Miltenyi Biotec, Bisley, UK). B cell preparations processes following BCR engagement.
were 90-95% pure as determined by flow cytometry. Like PI 3-kinase, the transcription factor NF-κB is activated in response to BCR stimulation. In primary B cells, NF-κB B cell stimulation is activated not only by BCR cross-linking, but also by B cells were cultured (at 2ϫ10 7 /ml for PI 3-kinase assays and lipopolysaccharide (LPS), phorbol esters and CD40 ligation at 1ϫ10 7 /ml for other experiments) and stimulated at 37°C in (28, 29) . The NF-κB/Rel transcription factor family of proteins RPMI 1640 medium supplemented with 20 mM HEPES, 50 include p50, p52, RelA, c-Rel and RelB, which form homo-µM 2-mercaptoethanol, 100 U/ml penicillin, 100 µg/ml streptoor heterodimers (30) . NF-κB/Rel dimers are sequestered in mycin and 2 mM glutamine [and 5% FCS for electrophoretic the cytoplasm in an inactive complex bound to members of mobility shift assays (EMSA)]. Cells were untreated or pre-IκB family of inhibitory proteins such as IκBα (31) . Upon treated for 30 min with the PI 3-kinase inhibitors Wortmannin cellular activation, IκBα is rapidly phosphorylated by a multi-(Calbiochem, Nottingham, UK) or LY294002 (Calbiochem) at component IκB kinase (IKK), which targets the inhibitor for the concentrations indicated. Further experiments used the degradation by the ubiquitin-proteasome pathway (31) .
PKC inhibitor, Gö 6983 (Calbiochem), which was added to B Degradation of IκBα reveals the nuclear localization sequence cells for 30 min prior to stimulation. The optimal concentration of the NF-κB/Rel dimers which subsequently translocate to of Gö 6983 (500 nM) was determined as the lowest concentrathe nucleus where they regulate transcription of various target tion required to completely inhibit BCR-induced IκBα genes involved in immune and inflammatory responses degradation-a known PKC-dependent process. Cells were (32, 33) . then stimulated with 10 µg/ml anti-murine IgM F(abЈ) 2 (Jackson NF-κB is constitutively active in the nucleus of resting, ImmunoResearch, Westgrove, PA) for BCR cross-linking or peripheral B lymphocytes (34) . However, upon stimulation, 50 µg/ml LPS (Sigma, Poole, UK) for the times indicated. additional NF-κB nuclear translocation occurs. NF-κB/Rel Cells that were not stimulated were incubated under the same transcription factors are involved in many processes that are conditions for the duration of the stimulation. important for B cell development, differentiation and function (30, 33) . This is highlighted in studies of mice deficient in PI 3-kinase assay c-Rel, RelA, RelB or p50, which show a marked reduction in proliferative responses to stimulation with LPS, CD40 ligation Following stimulation, B cells were pelleted in a microcenrtifuge for 20 s and resuspended in 0.5 ml ice-cold lysis buffer and BCR cross-linking (35) (36) (37) (38) (39) . Further, mice expressing a trans-dominant form of IκBα, which blocks NF-κB mobilization [1% (v/v) Triton X-100, 50 mM Tris-HCl, pH 7.5, 10% (v/v) glycerol, 150 mM NaCl, 5 mM EDTA, 1 mM sodium vanadate, to the nucleus, show defects in BCR-induced proliferation and differentiation (40) . Interestingly, these defects in B cell 10 mM sodium fluoride, 1 mM sodium molybdate, 1 mM PMSF, 2 µg/ml aprotinin, 10 µg/ml soybean trypsin inhibitor, function were strikingly similar to those observed in the mice lacking the regulatory subunit of PI 3-kinase (14,15).
5 µg/ml leupeptin and 0.7 µg/ml pepstatin]. 
4). The washed
Following stimulation, cells were lysed at 5ϫ10 6 cell equivaimmunoprecipitates were resuspended in 40 µl kinase buffer lents/ 40 µl in ice-cold lysis buffer. Proteins were resolved by and 50 µl of a lipid mixture [0.5 mg/ml phosphatidylinositol SDS-PAGE on 10% acrylamide gels, transferred to nitrocellu-(PtdIns) and 0.5 mg/ml phosphatidylserine (Sigma), dispersed lose (BioRad), and blocked overnight in 5% BSA and 1% by sonication in 25 mM HEPES, pH 7.4, and 1 mM EDTA].
ovalbumin in Tris-buffered saline. Primary antibodies were The reaction was initiated by the addition of 10 µCi of used at 1 µg/ml for anti IκBα (C-21; Santa Cruz), 1:100 dilution [γ-32 P]ATP (ICN Biomedicals, Basingstoke, UK) and 100 µM of anti-actin (Sigma), 1:1000 dilution of anti-phospho 473 Akt ATP, and terminated after a 15 min incubation at room (NEB, Hitchin, UK) and 1:1000 dilution of rabbit polyclonal temperature by the addition of 100 µl HCl (1 M) and 200 µl anti-Akt (a kind gift from Professor J. Tavare, University of chloroform:methanol (1:1). After vigorous mixing and centrifuBristol). Goat anti-rabbit horseradish peroxidase-conjugated gation to separate the phases, the organic layer was removed.
secondary antibody (Dako, High Wycombe, UK) was used at The extracted phospholipids were then spotted into silica gel 0.03 µg/ml. Immunoblots were developed using the ECL TLC plates that had been impregnated with 1% potassium system and Hyperfilm (Amersham Pharmacia Biotech, Little oxalate and developed in 1-propanol:acetic acid (2 N) (65: 35 Chalfont, UK). (v/v) for 16 h. The TLC plates were stained with iodine to confirm even extraction of substrate lipid between individual Results samples and 32 P-labelled PI 3-P was visualized by autoradiography. The identity of PI 3-P was confirmed by its sensitivity
BCR-induced activation of NF-κB is blocked by PI 3-kinase to the PI 3-kinase inhibitors Wortmannin and LY294002. inhibitors Preparation of nuclear extracts
Preliminary experiments investigated the ability of specific inhibitors to block BCR-induced PI 3-kinase activity in primary B cells were stimulated as described above. Cells were washed once in HBSS and resuspended in 400 µl buffer A B cells. The inhibitors used were the microbial metabolite Wortmannin (44), along with a structurally distinct reversible (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, 1 mM sodium vanadate, 10 mM inhibitor, LY294002 (45), both of which have been shown to specifically block PI 3-kinase in multiple cell types. B cells sodium fluoride, 0.5 mM PMSF, 2 µg/ml aprotinin, 1 µg/ml leupeptin, 1 µg/ml pepstatin, 10 mM sodium molybdate, were stimulated with 10 µg/ml anti-murine IgM F(abЈ) 2 for the times indicated ( Fig. 1A) and PI 3-kinase activity was 0.15 mM spermine and 0.75 mM spermidine). After incubation on ice for 15 min, IGEPAL was added to a final concentration of determined by assaying the in vitro lipid kinase activity present in anti-phosphotyrosine immunoprecipitates. Enzymatic activ-0.3% and samples vortexed. After centrifugation, cytoplasmic proteins were removed and the pelleted nuclei were resusity was measured by incubating immunoprecipitates with PtdIns and [γ-32 P]ATP and visualizing 32 P-labelled PI 3-P by pended in 50 µl buffer C (20 mM HEPES, pH 7.9, 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 25% glycerol, 1 mM dithio-TLC. Treatment of the splenic B cells with anti-murine IgM F(abЈ) 2 resulted in a rapid and transient increase in PI 3-threitol, 1 mM sodium vanadate, 10 mM sodium fluoride, 0.5 mM PMSF, 2 µg/ml aprotinin, 1 µg/ml leupeptin, 1 µg/ml kinase activity, with maximal lipid kinase activity observed following 1-5 min stimulation (Fig. 1A) . This time course pepstatin and 10 mM sodium molybdate). After 15 min agitation at 4°C, the samples were centrifuged and superof BCR-induced PI 3-kinase activation is consistent with previously reported results (46). To examine the effects of natants, containing nuclear proteins, were transfered to a fresh vial and rapidly frozen by immersion in liquid nitrogen Wortmannin (Fig. 1B) and LY294002 (Fig. 1C) on BCR-induced PI 3-kinase activity, the splenic B cells were pretreated with and stored at -70°C.
various concentrations of the PI 3-kinase inhibitors for 30 min EMSA prior to stimulation with anti-murine IgM F(abЈ) for 5 min. BCRinduced PI 3-kinase activity was markedly reduced following Nuclear protein concentrations were determined by BioRad protein assay (BioRad, Hemel Hempstead, UK). Proteins the addition of 5 nM Wortmannin or 5 µM LY294002. Increasing the concentration of the inhibitors further reduced PI 3-kinase were normalized to a concentration of 2 µg/4 µl buffer C. An oligonucleotide containing the binding sequence for activity with basal levels being reached at 50 nM Wortmannin and 10 µM LY294002. NF-κB (5Ј-AGTTGAGGGGACTTTCCCAGGC-3Ј) (Promega, Southampton, UK) was end-labelled with [γ-32 P]ATP using
The effects of the PI 3-kinase inhibitors on BCR-induced NF-κB DNA-binding activity was next determined. Following T4 polynucleotide kinase (Boehringer Mannheim, Mannheim, Germany). Binding reactions were performed in a total volume pre-treatment with 50 nM Wortmannin, 10 µM LY294002 or media alone, B cells were stimulated with 10 µg/ml antiof 20 µl containing 38 mM KCl, 0.6 mM MgCl 2 , 7.5% (v/v) Fig. 1 . In primary murine splenic B cells, BCR cross-linking induces PI 3-kinase activity which can be inhibited by Wortmannin and LY294002. Primary B cells (2ϫ10 7 ) were stimulated with 10 µg/ml anti-IgM F(abЈ) 2 for the times indicated (A) or pretreated for 30 min with various concentrations of Wortmannin (B) or LY294002 (C) prior to stimulation with 10 µg/ml anti-IgM F(abЈ) 2 for 5 min. Lysates from these cells were immunoprecipitated with anti-phosphotyrosine antibodies and the precipitates were assayed for PI 3-kinase activity by in vitro lipid kinase assay using PtdIns as a substrate. Extraction and TLC separation of the lipid products were performed as described in Methods.
murine IgM F(abЈ) 2 for the times indicated, and nuclear extracts prepared and analysed for NF-κB DNA-binding contained some NF-κB-binding activity as NF-κB is constitutively active in the nucleus of B lymphocytes (34) . Upon BCR cross-linking, enhanced NF-κB DNA-binding activity was clearly evident after 30 min stimulation (Fig. 2B) , with DNA-DNA-binding activity was reduced to basal levels. These results strongly suggest that PI 3-kinase activity is required binding activity maximal after 2 h (Fig. 2A) . Pre-treatment of B cells with Wortmannin ( Fig. 2A) or LY294002 (Fig. 2B) for BCR-induced activation of NF-κB. completely inhibited BCR-induced NF-κB DNA-binding activ-PI 3-kinase inhibitors prevent BCR-induced IκBα degradation ity. The PI 3-kinase inhibitors did not inhibit the basal level of NF-κB activity in control cells, indicating that cell viability was
In unstimulated lymphocytes, the majority of NF-κB is retained in the cytoplasm by virtue of its interaction with members of not affected by these inhibitors over the relatively short duration of the experiment, and only inhibited the BCRthe IκB family of inhibitors (31) . In the majority of cases migration of NF-κB to the nucleus follows the phosphorylation induced NF-κB activity to this basal level.
To extend these findings, we next examined the doseand subsequent degradation of IκBα exposing nuclear localization sequences on the released NF-κB/Rel dimers. In the response of the inhibitory effect of Wortmannin and LY294002 on BCR-induced NF-κB DNA-binding activity (Fig. 2C) . At 10 nuclear compartment, NF-κB stimulates transcription of many growth-related genes as well as the gene encoding IκBα. To nM Wortmannin and 5 µM LY294002, BCR-induced NF-κB Fig. 4 . LPS induces an increase in PI 3-kinase activity, which is sensitive to Wortmannin and LY294002. Primary B cells (2ϫ10 7 ) were stimulated with 50 µg/ml LPS for the times indicated (A) or pretreated for 30 min with 50 nM Wortmannin or 10 µM LY294002 prior to stimulation with LPS for 30 min (B). Anti-phosphotyrosine immunoprecipitates of the resulting cell lysates were then assayed for PI 3-kinase activity by in vitro lipid kinase assay as described in Methods. that BCR-induced NF-κB activation is mediated through a extracts were prepared and proteins separated by SDS-PAGE on PKC-dependent signaling pathway (28, 29) . Therefore, at least 10% acrylamide gels as described in Methods. The gels were transferred to nitrocellulose and probed with anti-IκBα antibodies two independent signaling pathways exist in B cells which dependent on PKC, but also on PI 3-kinase, we were interested in determining if the LPS-induced pathway to NF-κB activation also involved PI 3-kinase.
While earlier reports indicated that LPS-induced signalling determine whether the inhibitory action of Wortmannin and LY294002 was due to its effects on IκBα degradation, levels in B cells occurs independently of lipid turnover (47), a recent study using Wortmannin and LY294002 demonstrated that of IκBα protein were examined by Western blotting. In these experiments, the primary murine B cells were first exposed LPS-mediated B cell proliferation (over 48 h) is dependent on PI 3-kinase (48) . It was therefore important to directly to cyclohexamide to prevent de novo synthesis of IκBα. Then, cells were either pre-treated with Wortmannin (Fig. 3A) or measure whether LPS triggers the activation of PI 3-kinase before investigating the effects of Wortmannin and LY294002 LY294002 (Fig. 3B ) and the BCR cross-linked for the times indicated. Consistent with the findings that BCR-induced on NF-κB activation. Thus, PI 3-kinase activation in response to LPS in our primary splenic B cells was determined by NF-κB activation is dependent on PI 3-kinase activity, pre-treatment of B cells with either Wortmannin or LY294002 in vitro lipid kinase assay. An increase in PI 3-kinase activity was observed following 10 min stimulation with LPS, which inhibited BCR-induced degradation of IκBα. IκBα degradation was visible after 30 min of BCR cross-linking and most was sustained for 60 min (Fig. 4) . This LPS-induced PI 3-kinase activation was less intense and had a delayed onset prominent after 2 h. These data suggest that PI 3-kinase is involved in a signaling pathway leading to IκBα degradation when compared with BCR-induced PI 3-kinase activity (which was maximal following 1-5 min stimulation; Fig. 1A ). which results in NF-κB nuclear translocation and DNA-binding activity.
To confirm the involvement of PKC in the BCR-and LPSinduced pathways leading to NF-κB activation, the effects on
LPS-induced NF-κB DNA-binding activity and IκBα degrada-BCR-and LPS-induced IκBα degradation by a specific inhibtion is also inhibited by Wortmannin and LY294002
itor of PKC, Gö 6983, was determined. Gö 6983 specifically inhibits a number of PKC isoforms (α, β, γ, δ and ζ), but the In B cells, NF-κB can be activated not only by BCR crosslinking, but also by LPS and CD40 ligation (28, 29) . However, effects of this inhibitor on some novel and atypical PKC have not been tested. LPS has previously been shown to induce stimulation of NF-κB activity by both LPS and CD40 ligation is not affected by incubation overnight with phorbol myristate IκBα degradation in B cells (49). As shown in Fig. 5(A) , inhibition of PKC by Gö 6983 completely blocked BCR-induced acetate (PMA), suggesting that it occurs via a PKC-independ- 2 or 50 µg/ml LPS for 2 h, cytoplasmic extracts were prepared and proteins separated by SDS-PAGE on 10% acrylamide gels. The gels were transferred to nitrocellulose and probed with anti-IκBα antibodies (A, C and D: upper panels). The blots were then stripped and re-probed with antibodies against actin (lower panels) to demonstrate equal protein loading. The positions of IκBα and actin are indicated. (B) Nuclear extracts were prepared from primary B cells (1ϫ10 7 ) pre-treated for 30 min with either 50 nM Wortmannin or 10 µM LY294002 and then stimulated with 10 µg/ml anti-IgM F(abЈ) 2 or 50 µg/ml LPS for 2 h. NF-κB DNA-binding activity was analysed by EMSA using a 32 P-labelled oligonucleotide probe containing the NF-κB-binding sequence.
IκBα degradation but had no effect on LPS-induced IκBα
Lipopolysaccharide induces PI 3-kinase-dependent phosphorylation of Akt on serine 473 degradation, corresponding with the previously reported results (28, 29) . The effects of PI 3-kinase inhibition on LPS-A principle downstream mediator of PI 3-kinase-dependent induced NF-κB DNA-binding activity was next assessed. LPSsignaling processes is the serine/threonine kinase Akt. The induced NF-κB DNA-binding activity was inhibited to basal activation of Akt is controlled by phosphorylation of threonine levels by both Wortmannin and LY294002 (Fig. 5B) . Again, 308 and serine 473 (24) . While BCR engagement is known to unstimulated samples were incubated with the PI 3-kinase activate Akt in a PI 3-kinase dependent manner (16,17), the inhibitors for the duration of the experiment. The inhibitors did effects of LPS on Akt activity have not been studied. In order to not affect the basal level of NF-κB activity in these unstimulated test this, we stimulated primary murine B cells for various times cells, indicating that viability was not significantly affected by with either LPS or anti-IgM F(abЈ) 2 and performed anti-phospho these inhibitors over the short duration of the experiment. To Akt immunoblots. The results in Fig. 6(A) show that Akt is not complement these findings, the effects on IκBα degradation phosphorylated to a significant extent in unstimulated cells and was assessed. Both Wortmannin and LY294002 inhibited LPSconfirms that BCR ligation causes a substantial increase in induced IκBα degradation (Fig. 5C) . To address the sensitivity phosphorylation of Akt on serine 473. This was evident 2 min of these two pathways to PI 3-kinase inhibition, the effects on after stimulation and was sustained for at least 2 h. Importantly, IκBα degradation following treatment with various concentrastimulation with LPS also caused a clear increase in Akt tion of LY294002 was determined. As can be seen in Fig. 5(D) , phosphorylation on serine 473. The phosphorylation of Akt after both BCR-and LPS-induced degradation of IκBα were equally LPS stimulation was slightly delayed (correlating with the sensitive to the effects of LY294002. Thus, LPS appears to delayed onset of LPS-induced PI 3-kinase activation; Fig. 4A ), activate NF-κB through a PI 3-kinase-dependent pathway, sugbeing detectable at 30 min and remaining increased at 2 h. gesting that PI 3-kinase is important in two distinct pathways
To test whether LPS-induced phosphorylation of Akt on serine 473 is dependent on PI 3-kinase activity, we tested whether this leading to NF-κB activation. response could be blocked by Wortmannin and LY294002. Figure 6 (B) shows that Wortmannin and LY294002 not only blocked BCR-induced phosphorylation of Akt, confirming the previously reported results (16,17), but also blocked stimulation by LPS. Thus, it appears that LPS is capable of activating Akt in a PI 3-kinase-dependent manner.
Finally, we investigated the involvement of PKC in BCR-and LPS-induced phosphorylation of Akt on serine 473. The PKC inhibitor Gö 6983 had no effect on BCR-or LPS-induced phosphorylation of Akt (Fig. 6C) , suggesting that activation of Akt does not occur downstream of activation of PKC in this system.
Discussion
NF-κB was first described as a potent regulator of Igκ transcription in B cells but is now known to control expression of numerous genes involved in immune and inflammatory responses (32, 33) . Despite its importance in B cell function, little is known about the downstream events following BCR engagement leading to NF-κB activation. Using the PI 3-kinase inhibitors Wortmannin and LY294002, the results presented here demonstrate that PI 3-kinase is required for both BCR-and LPS-induced NF-κB DNA-binding activity and associated degradation of IκBα.
BCR cross-linking induced the formation of NF-κB DNA-binding complexes which migrated as two distinct bands as revealed by EMSA. These bands are characteristic of NF-κB, and correspond to the presence of both homo-and heterodimers of individual NF-κB/Rel family proteins. Indeed, supershift analysis confirmed the previously reported finding (50) that BCR cross-linking induced DNA-binding activity of complexes containing p65, c-rel, RelB and p50 (data not shown). The degradation together with an earlier report which showed that and stimulation of a human hepatoma cell line with IL-1 and pre-treatment of B cells with PMA prevented NF-κB activation tumor necrosis factor (TNF)-α (54) (55) (56) . In addition, a major (28, 29) demonstrate a critical role for PKC in this process. The downstream effector of PI 3-kinase, Akt, has recently been involvement of PKC is not consistent with a putative role for Akt shown to be involved in NF-κB activation in some systems (41- in BCR-induced NF-κB activation since Akt has been reported 43). In Jurkat T cells, over-expression of Akt was shown to to mediate its effects through direct interaction and phosphoenhance NF-κB activation, following stimulation with PMA and rylation of IKK (42, 43) . Furthermore, our results show that ionomycin (41) . Further, NF-κB activation stimulated by plate-Gö 6983 had no effect on BCR-induced Akt phosphorylation, let-derived growth factor in fibroblasts (43) and TNF in embryindicating that the critical PKC involved in BCR-induced NF-κB onic kidney cells (42) was shown to involve the activation of Akt activation is not upstream of Akt in this system. In addition, and its interaction with IKK.
phosphorylation of Akt at serine 473 occurs normally following While BCR engagement activates Akt via a PI 3-kinase-BCR cross-linking in Btk-deficient DT40 cells (17) despite the dependent pathway (16,17 and the results of this study), it is fact that Btk is required for BCR-induced NF-κB activation (see unlikely that PI 3-kinase-dependent BCR-induced activation of below). This provides further evidence that BCR-induced NF-NF-κB occurs via an Akt-dependent route. Our finding that a κB activation does not occur through an Akt-dependent pathway. specific inhibitor of PKC, Gö 6983, blocks BCR-induced IκBα Fig. 7 . NF-κB activation via PI 3-kinase. Based on the results presented here and on evidence from previous reports, the following model of PI 3-kinase-dependent NF-κB activation can be proposed. BCR-induced activation of PI 3-kinase results in accumulation of PI(3,4,5)P 3 levels at the membrane to which the PH domains of Btk and PDK1 bind, facilitating their translocation to the plasma membrane. This results in activation of PKC, either via PDK1 or the PLC-γ2 pathway, and consequently triggers the activation of IKK. IKK-mediated phosphorylation of IκBα results in its degradation, allowing translocation of NF-κB to the nucleus. BCR-induced NF-κB activation is unlikely to occur via Akt (dashed line) since BCR-induced NF-κB activation is not only dependent on PI 3-kinase but also on PKC and Akt phosphorylation does not occur downstream of PKC. However, LPS-induced NF-κB activation, which also depends on PI 3-kinase activity, is unlikely to be dependent on PKC. LPS was also shown to be capable of triggering Akt phosphorylation on serine 473, thus it is possible that LPS could activate NF-κB through this Akt-dependent pathway.
How might PI 3-kinase act through PKC to trigger NF-κB not necessary for CD40-or LPS-induced activation of NF-κB in B cells (28, 29) . In addition, we were able to inhibit BCR-but not activation? The major outcome of PI 3-kinase activity is the generation of PI(3,4,5)P 3 which facilitates the recruitment, via LPS-induced IκBα degradation with the PKC inhibitor Gö 6983. Taken together, these findings suggest that LPS-induced NF-PH domains, of a variety of proteins to the cell membrane. One of the key proteins recruited in this way is the Tec family kinase κB activation occurs through a PKC-independent pathway. However, it is important to note that Gö 6983 does not block the Btk; a critical factor in BCR-induced PLC-γ2 mobilization leading to Ca 2ϩ flux and diacylglycerol-associated PKC activation. activation of some novel or atypical PKC and therefore their role in the LPS-induced pathway cannot be ruled out. Despite Indeed xid mice, which lack functional Btk, exhibit greatly diminished BCR-induced NF-κB activation (57,58). In addition, this, our findings clearly demonstrate the presence of two distinct pathways activated through the BCR and by LPS, leading PDK1, a serine/threonine kinase, is also recruited to the plasma membrane via its PH domain, and has been shown to phosto IκBα degradation (one which is Gö 6983 sensitive and the other which is Gö 6983 insensitive). Interestingly, the LPSphorylate and activate PKC ζ and δ (59). The precise isoform of PKC which is responsible for NF-κB activation following BCR induced pathway to NF-κB activation was also dependent on PI 3-kinase activity. We show here for the first time that LPS can cross-linking remains unclear. In a variety of systems, PKC ζ and λ have been shown to be critical in activation of NF-κB directly activate PI 3-kinase activity. Inhibiting this PI 3-kinase activity with either Wortmannin or LY294002 inhibited LPSthrough the IKK pathway and directly bind the IKK in vitro and in vivo (60) (61) (62) . In B cells PKC α, β, γ, δ, ζ, η and µ have been induced NF-κB DNA-binding activity and LPS-induced IκBα degradation. As with BCR-induced NF-κB, supershift analysis detected (63, 64) , and PKC β (65), µ and δ (66) have been shown to be involved in BCR signaling. Thus, following BCRrevealed the presence of complexes containing p50, p65, crel and RelB, all of which were inhibited following pre-incubation induced activation of PI 3-kinase, recruitment of Btk and/or PDK1 to the plasma membrane could lead to PKC-induced NFwith LY294002 (data not shown). Our observations are interesting since a recent report has shown that LPS-induced NF-κB activation (Fig. 7) . Elucidation of the relative roles of Btk, PDK1 and the PKC isoforms involved will help determine the κB activation and IκBα degradation in Jurkat T cells, human epithelial cells and human glioma cells is dependent on both precise pathway leading to BCR-induced NF-κB activation.
However, in B cells, there is a distinct signaling pathway(s), PI 3-kinase and PKC (67) . Therefore, the LPS-induced NF-κB activation in B cells occurs through a pathway which is distinct not mediated through the BCR, leading to NF-κB activation. It has previously been shown, through depletion using PMA, that from that in other cells types.
The precise processes linking PI 3-kinase to NF-κB following while PKC is necessary for BCR-induced NF-κB activation, it is
